News Image

Is NASDAQ:DXCM a Fit for Growth Investing Strategies?

By Mill Chart

Last update: Nov 22, 2023

In this article we will dive into DEXCOM INC (NASDAQ:DXCM) as a possible candidate for growth investing. Investors should always do their own research, but we noticed DEXCOM INC showing up in our Louis Navellier growth screen, which makes it worth to investigate a bit more.

A Deep Dive into DEXCOM INC's Growth Metrics.

  • DEXCOM INC demonstrates a strong Return on Equity(ROE) of 16.62%. This indicates the company's ability to generate favorable returns for shareholders and reflects its efficient utilization of capital. DEXCOM INC shows promising potential for continued success.
  • DEXCOM INC has consistently surpassed EPS estimates in the last 4 quarters, reflecting its strong financial performance and effective management. This trend suggests the company's ability to generate positive earnings surprises and drive shareholder value.
  • The 1-year revenue growth of DEXCOM INC (21.85%) has been strong, reflecting the company's ability to generate consistent sales growth. This growth suggests the company's ability to meet customer needs and expand its market share.
  • With impressive quarter-to-quarter (Q2Q) revenue growth of 26.69%, DEXCOM INC showcases its ability to generate increased sales and revenue. This growth indicates the company's strong customer demand and its effective business strategies.
  • With a favorable trend in its operating margin over the past year, DEXCOM INC demonstrates its ability to enhance profitability through efficient operations. This growth reflects the company's focus on optimizing its cost structure.
  • DEXCOM INC has experienced notable growth in its free cash flow (FCF) over the past year, signaling improved cash generation and strong financial performance. This growth suggests the company's ability to generate excess cash for reinvestment or shareholder returns.
  • DEXCOM INC has shown positive momentum in its earnings per share (EPS) on a quarter-to-quarter (Q2Q) basis, with a 78.57% increase. This reflects the company's successful execution of its business strategies and its commitment to delivering improved financial results.
  • DEXCOM INC has seen a 10.41% change in the average next Quarter EPS Estimate by analysts over the last 3 months, signaling the shifting perception of the company's EPS outlook.
  • The recent financial report of DEXCOM INC demonstrates a 78.57% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
  • DEXCOM INC shows accelerating EPS growth: when comparing the current Q2Q growth of 78.57% to the previous year Q2Q growth of 25.84%, we see the growth rate improving.

What is the full fundamental picture of NASDAQ:DXCM telling us.

At ChartMill, a crucial aspect of their analysis is the assignment of a Fundamental Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous fundamental indicators and properties.

We assign a fundamental rating of 7 out of 10 to DXCM. DXCM was compared to 202 industry peers in the Health Care Equipment & Supplies industry. DXCM has an excellent profitability rating, but there are some minor concerns on its financial health. DXCM is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, DXCM could be worth investigating further for growth investing!.

Check the latest full fundamental report of DXCM for a complete fundamental analysis.

More growth stocks can be found in our Lois Navellier screen.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

DEXCOM INC

NASDAQ:DXCM (2/23/2024, 7:00:01 PM)

After market: 116.26 0 (0%)

116.26

-1.24 (-1.06%)

DXCM News

News Image2 days ago - The Motley FoolGot $1,000? Buy These Hot Growth Stocks Before They Take Off

If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.

News Image2 days ago - Seeking AlphaFDA warns against use of smartwatches to measure blood glucose

The FDA warns of risks associated with using smartwatches or smart rings claiming to measure blood glucose levels without piercing the skin.

News Image9 days ago - ChartmillDiscover the top S&P500 movers in Thursday's pre-market session and stay informed about market dynamics.

Which S&P500 stocks are moving before the opening bell on Thursday?

News Image9 days ago - InvestorPlace7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.

News Image9 days ago - Seeking AlphaTiger Global exits Alibaba, Pagaya; takes new stakes in DexCom, Broadcom (NASDAQ:DXCM)

Tiger Global Management's latest 13F filing reveals exits from Alibaba and other stocks, while taking new stakes in Dexcom and Broadcom.

News Image11 days ago - The Motley FoolThese 2 Growth Stocks Could Soar 33% and 45% According to Wall Street Analysts. Are They Smart Buys Now?

Expectations are high for companies making blood sugar monitors and business automation software.

News Image11 days ago - ChartmillThese S&P500 stocks are moving in today's session

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

News Image12 days ago - The Motley FoolWall Street's Next Stock-Split Stocks Are Liable to Be Familiar Names

Nine high-profile stocks -- Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk -- have split since mid-2021. Two of these companies appear ready for round two!

News Image14 days ago - The Motley Fool2 No-Brainer Healthcare Stocks to Buy Right Now

Companies in the healthcare industry tend to generate returns in a wide range of market environments.

News Image14 days ago - ChartmillTop S&P500 movers in Friday's session

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

News Image15 days ago - ChartmillTop S&P500 movers in Friday's session

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

News Image15 days ago - ChartmillCurious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Curious about the market action on Friday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

DXCM Links
Follow us for more